惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Recent Announcements
Recent Announcements
J
Java Code Geeks
U
Unit 42
GbyAI
GbyAI
大猫的无限游戏
大猫的无限游戏
L
LangChain Blog
D
Docker
F
Fortinet All Blogs
N
Netflix TechBlog - Medium
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
罗磊的独立博客
I
InfoQ
The Cloudflare Blog
小众软件
小众软件
V
Visual Studio Blog
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
Engineering at Meta
Engineering at Meta
S
SegmentFault 最新的问题
爱范儿
爱范儿
Hugging Face - Blog
Hugging Face - Blog
P
Proofpoint News Feed
V
V2EX
月光博客
月光博客
Martin Fowler
Martin Fowler

Ars Technica - All content

Pentagon wants $54B for drones, more than most nations’ military budgets Mozilla: Anthropic's Mythos found 271 security vulnerabilities in Firefox 150 Supreme Court arguments make it clear that FCC fines are "nonbinding" Silo S3 teaser hints at the wasteland's origins Framework's CEO on the RAM crisis and creating a "MacBook Pro for Linux users" Florida probes ChatGPT role in mass shooting. OpenAI says bot "not responsible." Report: Meta will train AI agents by tracking employees' mouse, keyboard use Microsoft removes Call of Duty from Game Pass, lowers subscription pricing Framework Laptop 13 Pro is a major overhaul for the modular, upgradeable laptop Framework Laptop 16 upgrades make it look less like an unfinished prototype Internal emails show how Amazon raises prices across the Internet, lawsuit says Anthropic gets $5B investment from Amazon, will use it to buy Amazon chips CATL's new LFP battery can charge from 10 to 98% in less than 7 minutes AMD Ryzen 9 9950X3D2 Dual Edition review: Tons of cache for tons of dollars What's the deal with spacesuits for the Moon? Will they be ready in time? Loneliness in older adults can often lead to memory impairment Contrary to popular superstition, AES 128 is just fine in a post-quantum world Pentagon pulls the plug on one of the military's most troubled space programs John Ternus will replace Tim Cook as Apple CEO Blue Origin's rocket reuse achievement marred by upper stage failure I’ve fired one of America’s most powerful lasers—here’s what a shot day looks like Great white sharks are overheating US-sanctioned currency exchange says $15 million heist done by "unfriendly states" Man with @ihackedthegovernment Instagram account tells judge, “I made a mistake" Trump picks qualified, normal health leader to head CDC; experts still cautious $25,000 buys plenty of used EVs: Here are some options Satellite and drone images reveal big delays in US data center construction Amazon won’t release Fire Sticks that support sideloading anymore Ridley Scott's post-apocalyptic The Dog Stars drops first trailer Artemis II pilot talks about what it was really like to fly and land in Orion
In rare chickenpox case, itchy blisters mushroom into lar...
Beth Mole · 2026-04-25 · via Ars Technica - All content

Unwieldy wounds

Healing from wounds has three main phases. The first is an inflammatory phase that prevents or limits further damage. There’s a proliferative phase during which new tissue is formed. Among the many things that occur in this phase, specialized cells called fibroblasts produce collagen that helps create structural suppors for new tissue. This proliferative phase isn’t discreet; it can go on in the background throughout the healing process. Last, there’s a maturation phase when the new tissue settles into its final form and gains maximum strength.

When keloids form, it means something went wrong in the proliferative phase of healing. Specifically, the fibroblasts of keloids are thought to be more active, survive longer, and produce more collagen and more signaling molecules that promote growth. Collagen production in keloids can be 20 times larger than in typical skin.

It’s unclear what triggers this uncontrolled tissue growth, but genetics and environmental factors are thought to play a role. Keloids are seen more often in people with darker skin. In the teen’s case, her doctors note that varicella infections are known to trigger certain pro-inflammatory cellular signals and speculate that they could potentially induce a hyperproliferative state. But, for now, it’s just a hypothesis.

Treatment for keloids is, unfortunately, difficult. When the problem is faulty wound healing, any treatment that creates new wounds risks failing or worsening the problem. Surgical removal, for instance, has recurrence rates between 45 percent to 100 percent. Cryotherapy can sometimes be used to kill off scar tissue, but it can also leave undesirable skin alterations. Laser and radiotherapy have been used, but with clear risks and sometimes limited results. Successful treatment often requires a combination of methods. The mainstay treatment, however, is injections with corticosteroids, which help with the itching and burning.

In the teen’s case, doctors monitored her keloids for three months and found they were relatively stable, with no rapid growth—though they could potentially continue to grow over time. Given preferences and financial limitations, she decided to forgo aggressive treatment and live with the growths, managing symptoms with antihistamines and over-the-counter painkiller acetaminophen.

While keloids remain a menace, chickenpox has an effective prevention. The varicella vaccine was released in the US in 1995, and two doses offer 97 percent protection. Since its debut, chickenpox cases—and complications—have declined dramatically.